Category: Health Science
-
![Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours]()
Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly, and before that we had crypto, and after cannabis’ untimely deflation in the summer of 2018, we were looking for the next source of market exuberance.…
-
![Aequus Pharmaceuticals (AQS.V) Sees All, Partners with ReVision Therapeutics to Tackle Stargardt Disease]()
Aequus Pharmaceuticals (AQS.V) Sees All, Partners with ReVision Therapeutics to Tackle Stargardt Disease
I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t enough to satiate my craving for sugar seeing as I would finish the entire thing in just a few days. Eventually, I grew out of my…
-
![Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea]()
Canntab Therapeutics (PILL.C): a pressing investment opportunity – Today’s Idea
Canntab Therapeutics (PILL.C) has been around the block and then some. The Ontario-based pharmaceutical answer to medicinal cannabis, has pioneered a patented process to turn CBD, THC and terpene and other cannabinoid distillates into hard-pressed pills that reliably deliver accurately measured dosages with optimal bioavailability. The company’s instant release and extended-release formulations round out a…
-
![Graphene Manufacturing Group (GMG.V) produces laboratory-grade graphene from methane gas]()
Graphene Manufacturing Group (GMG.V) produces laboratory-grade graphene from methane gas
Eight years ago, Physics World published an article announcing that graphene was a “miracle substance” so strong that a sheet of graphene the thickness of “Clingfilm” could support the weight of an elephant. “Graphene is a layer of carbon just one atom thick and since it was first isolated in 2004 its remarkable electronic and…
-
![Filament Health (FN.NEO) – Five Easy Questions with Maddy]()
Filament Health (FN.NEO) – Five Easy Questions with Maddy
Welcome to Five Easy Questions with Maddy Grace where we explain the public markets and the companies that trade on them. In today’s episode, Maddy speaks with Ben Lightburn, CEO of Filament Health, a new psychedelics company with a patented process for extracting compounds naturally and bottling them in consistent dose levels. Enjoy!
-
![BetterLife Pharma (BETR.C) products show promise, but how’s their timing?]()
BetterLife Pharma (BETR.C) products show promise, but how’s their timing?
Drug science is all about timing. You can either take a preexisting molecule, which has benefits for alternative indications rather than what it’s originally on shelves for, and you after proving that it has these benefits during the regulatory dance, you take it to a new market, rebrand it and resell it. Easy. Or you…
-
![Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development]()
Analysis: BetterLife (BETR.C) implements a business-minded and cost-conscious approach to product research and development
BetterLife is a biotechnology company that develops and commercializes psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. Products Although the table below may seem complex is just a collection of the product names or titles and a description with the type of disease the product…
-
![To Invest or Not: BetterLife Pharma (BETR.C)]()
To Invest or Not: BetterLife Pharma (BETR.C)
In this episode, we look at BetterLife Sciences (BETR.C), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. We check out their product pipeline and stock price to get a better idea of what the future may hold for potential investors.
-
![To Invest or Not: Element Nutritional Sciences (ELMT.C)]()
To Invest or Not: Element Nutritional Sciences (ELMT.C)
In this episode, we take to look at Element Nutritional Sciences (ELMT.C) a nutraceutical company that uses plant-based technology and extensive nutritional research to create health-driven products for customers. We look at the company’s finances, stock price and flagship product Rejuvenate, a proprietary formulation to assist in the rebuilding, restoration, and rejuvenation of natural loss…
-
![Element Nutrition (ELMT.C) leapfrogs almost the entire plant-based sector with mondo Walgreens drug store deal]()
Element Nutrition (ELMT.C) leapfrogs almost the entire plant-based sector with mondo Walgreens drug store deal
If you like plant-based companies on the public markets; if you think veganism and vegetarianism and pescatarianism and whole-foodism and ‘health and wellness’ism are all a positive thing, as I do, and as it seems a lot of investors do, then you’ve no shortage of stock tickers that’ll claim to be leading the space. But…
